Britain to provide anti-viral drug remdesivir to some COVID-19 patients

In this file photo taken on April 08, 2020, vials of the drug Remdesivir sit on a table during a press conference about the start of a study of the Ebola drug in severely ill COVID-19 patients, at the University Hospital Eppendorf in Hamburg, Germany. (AFP)
Short Url
Updated 26 May 2020
Follow

Britain to provide anti-viral drug remdesivir to some COVID-19 patients

  • Early data from clinical trials showed that the drug could shorten the recovery time of COVID-19 patients by four days

LONDON: Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said on Tuesday.
The department of health said early data from clinical trials around the world showed that the drug could shorten the recovery time of COVID-19 patients by four days.
“As we navigate this unprecedented period, we must be on the front foot of the latest medical advancements, while always ensuring patient safety remains a top priority,” junior health minister James Bethell said.
“We will continue to monitor remdesivir’s success in clinical trials across the country to ensure the best results for UK patients.”
The government said the allocation of the drug would be determined by where it would have the greatest benefit, but did not say how many patients would be treated.
The US National Institutes of Health (NIH) said last week that data from its trial of remdesivir showed that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.
The researchers also said that “given high mortality despite the use of remdesivir,” it is likely that the drug would be more effective in combination with other treatments for COVID-19, the respiratory illness caused by the novel coronavirus.
Stephen Griffin, an associate professor at Leeds University, welcomed the move to use remdesivir, saying it would “likely mean that the most severe COVID-19 patients will receive it first.” He said that while this approach was the most ethical, it also meant drug would not be a “magic bullet.”
“We can instead hope for improved recovery rates and a reduction in patient mortality,” Griffin said.
Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month.


US accuses South Africa of harassing US officials working with Afrikaners

Updated 59 min 37 sec ago
Follow

US accuses South Africa of harassing US officials working with Afrikaners

  • The State Department alleged that Americans had also been briefly held in the raid, which it said the United States “condemns in the strongest terms.”

WASHINGTON: Washington on Thursday accused South Africa of harassing US government employees working with Afrikaners, the white minority to whom President Donald Trump is granting refugee status, in the latest escalation of tensions.
The State Department said that passport information of US officials was leaked and warned in a statement that “failure by the South African government to hold those responsible accountable will result in severe consequences.”
South Africa replied that the allegation was unsubstantiated and rejected “any suggestion of state involvement in such actions.”
The accusations came after South Africa arrested and expelled Wednesday seven Kenyans brought in by the US government to assist in processing Afrikaners seeking to move to the United States.
President Donald Trump’s administration has claimed Afrikaners are victims of discrimination and even “genocide,” which the Pretoria government strongly denies.
South Africa said the Kenyans arrested at a processing center on Tuesday were on tourist visas that did not allow them to work — the type of violation seized on by Trump as he carries out mass deportations from the United States.
The State Department alleged that Americans had also been briefly held in the raid, which it said the United States “condemns in the strongest terms.”
It added that officials’ passport information had been made public.
So-called doxxing, or revealing personal information, “is an unacceptable form of harassment” and puts people in harm’s way, the State Department said.
It did not immediately provide further details on the purported incident.

‘Seeking clarity’ 

South Africa “noted an unsubstantiated allegation regarding the private information” and was seeking clarity from Washington, the foreign ministry in Pretoria said later.
“We categorically reject any suggestion of state involvement in such actions,” it said in a statement.
The government has already said no US officials were arrested in Tuesday’s raid, which was not carried out at a diplomatic site.
The seven Kenyan nationals who were expelled had violated South African law by working without the correct permits, the foreign ministry repeated.
“The government will not negotiate its sovereignty and the implementation of the rule of law,” it said.
Trump has repeatedly attacked South Africa’s post-apartheid government over what he calls persecution of the Afrikaners, an allegation that had gained ground online with the far-right.
He has been increasingly open on his desire to rid the United States of immigrants other than white Europeans and all but ended the once-generous US refugee resettlement program, which now only accepts Afrikaners among all the world’s people.
The State Department in a separate statement Thursday confirmed it did not invite South Africa to an initial meeting on planning next year’s Group of 20 summit, the first time a member of the bloc is being excluded.